Cipher Pharmaceuticals Inc. — Investor Relations & Filings
Filings indexed
165
across all filing types
Latest filing
2025-03-18
Regulatory Filings
Country
CA
Canada
Listing
TSX
CPHRF
Cipher Pharmaceuticals Inc. is a specialty pharmaceutical company focused on acquiring, marketing, and managing a diversified portfolio of commercial and pipeline products, primarily within the dermatology sector. The company seeks to fulfill unmet medical needs by acquiring best-in-class products and managing the necessary clinical development and regulatory processes. Its portfolio includes key commercial products such as Epuris (isotretinoin), an oral retinoid indicated for the treatment of acne. Cipher's strategy involves continually evaluating businesses with commercial products for merger or acquisition opportunities to expand its offerings.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Annual MD&A - English.pdf | 2025-03-18 | English | |
| Audited annual financial statements – English.pdf | 2025-03-18 | English | |
| News release - English.pdf | 2025-03-18 | English | |
| News release - English.pdf | 2025-03-11 | English | |
| News release - English.pdf | 2024-12-10 | English | |
| News release - English.pdf | 2024-11-04 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
4 filings
| |||||
| 13777785 | Annual MD&A - English.pdf | 2025-03-18 | English | ||
| 13777787 | Audited annual financial statements – English.pdf | 2025-03-18 | English | ||
| 13777819 | News release - English.pdf | 2025-03-18 | English | ||
| 13775015 | News release - English.pdf | 2025-03-11 | English | ||
|
2024
11 filings
| |||||
| 31382537 | News release - English.pdf | 2024-12-10 | English | ||
| 30976061 | News release - English.pdf | 2024-11-04 | English | ||
| 30796331 | Business acquisition report - English.pdf | 2024-10-10 | English | ||
| 13753264 | Material contracts - Credit agreements.pdf | 2024-10-09 | English | ||
| 13753267 | Material document(s).pdf | 2024-10-09 | English | ||
| 13750640 | News release - English.pdf | 2024-09-13 | English | ||
| 30461771 | Material change report - English.pdf | 2024-08-02 | English | ||
| 13745313 | News release - English.pdf | 2024-08-01 | English | ||
| 13744679 | Report of Distributions outside Canada (Form 72-503F).pdf | 2024-07-31 | English | ||
| 13740069 | News release - English.pdf | 2024-06-14 | English | ||
| 30139415 | Management information circular - English.pdf | 2024-05-23 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Cipher Pharmaceuticals Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/45392/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=45392 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=45392 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=45392 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 45392}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Cipher Pharmaceuticals Inc. (id: 45392)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.